Please try another search
ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Name | Age | Since | Title |
---|---|---|---|
Chikafumi Yokoyama | 56 | 2005 | CEO, President & Representative Director |
Daisuke Usui | 51 | 2016 | COO & Director |
Yoshiyuki Yamakawa | 62 | 2008 | Independent Outside Director |
Nobuhisa Yamazaki | 70 | 2022 | Outside Audit & Supervisory Board Member |
Takanori Kushida | 47 | 2017 | Outside Audit & Supervisory Board Member |
Yoshiyuki Murai | 60 | 2020 | Outside Audit & Supervisory Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review